Message from the President and CEO

NASDAQ: 2.29

TSX: 2.89

FR - EN
Logo Thera
  • About
    • Our history
    • Board of Directors
    • Leadership Team
    • Scientific Consultants and Advisors
    • Awards
    • COVID 19
  • Commercialized products
    • Trogarzo®
    • EGRIFTA®
    • EGRIFTA SV®
  • Product Pipeline
  • Investors
    • Overview
    • Investor Presentations
    • News
    • Financial Reports and Public Filings
    • Corporate Governance
    • Analysts
    • FAQ
  • Careers
  • Contact
    • Contact information
    • Email alerts
    • RSS Feed
  • Icone loupe
    RechercheIcone loupe
  • FR - EN
  • About
    • Our history
    • Board of Directors
    • Leadership Team
    • Scientific Consultants and Advisors
    • Awards
    • COVID 19
  • Commercialized products
    • Trogarzo®
    • EGRIFTA®
    • EGRIFTA SV®
  • Product Pipeline
  • Investors
    • Overview
    • Investor Presentations
    • News
    • Financial Reports and Public Filings
    • Corporate Governance
    • Analysts
    • FAQ
  • Careers
  • Contact
    • Contact information
    • Email alerts
    • RSS Feed
  • Icone loupe
    RechercheIcone loupe
  • FR - EN

Search Results for

November 23, 2020
Theratechnologies To Present At The Piper Sandler Virtual Healthcare Conference
Theratechnologies To Present At The Piper Sandler Virtual Healthcare Conference

Montreal, Canada – November 23, 2020 – Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that some of its management team members will be participating in the upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference on December 1 and 2, 2020.

Fireside Chat – Piper Sandler Virtual Healthcare Conference
Fireside Chat – Piper Sandler Virtual Healthcare Conference

Conference: Piper Sandler Virtual Healthcare Conference Pre-recorded fireside chat link:  https://pipersandler.zoom.us/rec/play/DzM2ijjKkXgWuhzWySeHQJNIC4BQ6Ogr5J0niJyS3ssfq5mHVItC87xcOsLrajOpcg40gTuwOGssIeyW.e9WptH4CKoRvgK5k

November 16, 2020
Theratechnologies Announces Data From Oral Presentation At AASLD Showing How Tesamorelin Can Reduce Fibrosis And NASH
Theratechnologies Announces Data From Oral Presentation At AASLD Showing How Tesamorelin Can Reduce Fibrosis And NASH

Montreal, Canada – November 16, 2020 – Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today highlighted new data on the mechanism of effect of tesamorelin presented in an oral presentation given today by Lindsay T. Fourman, M.D., of the Metabolism Unit, Department of …Lire la suite

November 09, 2020
Theratechnologies’ Presentation at the Credit Suisse Virtual Healthcare Conference
Theratechnologies’ Presentation at the Credit Suisse Virtual Healthcare Conference

Conference: Credit Suisse Virtual Healthcare Conference Date and Time: Tuesday, November 10, 2020 at 8:45 a.m. ET Webcast Link: https://kvgo.com/credit-suisse/theratech-november-2020

November 06, 2020
Theratechnologies Announces That Data On The Mechanism Of Effect Of Tesamorelin In NAFLD Will Be Presented At The Liver Meeting® 2020
Theratechnologies Announces That Data On The Mechanism Of Effect Of Tesamorelin In NAFLD Will Be Presented At The Liver Meeting® 2020

Montreal, Canada – November 6, 2020 – Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that an oral presentation including data on the mechanism of effect of tesamorelin in nonalcoholic fatty liver disease (NAFLD) will be given by Lindsay T Fourman, MD, …Lire la suite

November 03, 2020
Theratechnologies Announces Departure Of Chief Commercial Officer
Theratechnologies Announces Departure Of Chief Commercial Officer

Montreal, Canada – November 3, 2020 – Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Jovan Antunovic, Senior Vice President and Chief Commercial Officer, is leaving the Company to assume a new position. His resignation will be effective November 13, 2020. …Lire la suite

October 28, 2020
Theratechnologies’ Presentation at the B. Riley Securities Liver Disease Therapeutics Day 2020
Theratechnologies’ Presentation at the B. Riley Securities Liver Disease Therapeutics Day 2020

Conference:  B. Riley Securities Liver Disease Therapeutics Day 2020 Date and Time:  Thursday, October 29, 2020 at 12:10 pm ET Webcast Link:  https://www.webcaster4.com/Webcast/Page/2433/38305 B. Riley Representative:  Mayank Mamtani

October 22, 2020
Theratechnologies To Present At Upcoming Investor Conferences On October 29 And November 10, 2020
Theratechnologies To Present At Upcoming Investor Conferences On October 29 And November 10, 2020

Montreal, Canada – October 22, 2020 – Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that management will be presenting at the following upcoming virtual investor conferences. Riley Securities Liver Disease Therapeutics Day Thursday, October 29, 2020 Panel discussion with Dr. Christian …Lire la suite

October 20, 2020
Alain Trudeau
Alain Trudeau

A fellow of the Quebec CPA Order, Alain Trudeau has had a distinguished career at Ernst & Young from 1982 to 2019 where he held the position of Managing Partner, Assurance Services, for EY offices in the Province of Quebec from 2008 to 2019. He was also responsible for the audit of many publicly-traded companies. …Lire la suite

Andrew Molson
Andrew Molson

Andrew Molson serves as chairman of AVENIR GLOBAL, an organization uniting seven strategic communications firms across Canada, the U.S., Europe and the Middle East. He is also chairman of Molson Coors Beverage Company and a member of the board of directors of Groupe Deschênes Inc., Dundee Corporation and the CH Group Limited Partnership, owner of …Lire la suite

Posts navigation

Older posts
Newer posts
Investors area
About
Jobs available

Would you like to be informed about the latest releases?

You will automatically receive new information by email (events, news, press releases ...)

Logo
  • About
  • Commercialized products
  • Product Pipeline
  • Investors
  • Careers
  • Contact

Email alerts
RSS

©2019 - Theratechnologies Inc.

Terms of use

Privacy